ClinConnect ClinConnect Logo
Search / Trial NCT05475600

APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU

Launched by CENTRE HOSPITALIER RÉGIONAL METZ-THIONVILLE · Jul 25, 2022

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating how adapted physical activity (APA) can help reduce anxiety in patients with serious blood diseases who are in the Intensive Care Unit (ICU). The researchers want to see if different types of activities, such as traditional exercises, video game-based exercises (known as Exergaming), and relaxation techniques combined with biofeedback (a method that helps people learn to control their body functions) can make a difference in the anxiety levels of these patients. The goal is to find out if these activities can not only ease anxiety but also help patients maintain their physical abilities during a tough time.

To participate in this trial, individuals need to be between 18 and 75 years old and currently admitted to the ICU. They must also be able to provide informed consent, meaning they understand what the study involves. However, those who cannot exercise for health reasons, do not speak French, are involved in another research study, or do not have social security coverage will not be eligible. Participants can expect to engage in different activity programs designed to improve their well-being while being closely monitored by healthcare professionals.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects aged between 18 and 75 years old
  • Admitted in Intensive Care Unit
  • Informed consent
  • Exclusion Criteria:
  • Contraindication for physical exercise
  • Inability to understand the French language (written and/or oral)
  • Ongoing involvement in another proprietary research protocol
  • Lack of affiliation to social security

About Centre Hospitalier Régional Metz Thionville

The Centre Hospitalier Régional Metz-Thionville is a leading healthcare institution in the Grand Est region of France, dedicated to delivering high-quality medical care and advancing clinical research. With a multidisciplinary team of experienced healthcare professionals, the center emphasizes patient-centered services and innovative treatment approaches. Committed to enhancing medical knowledge and improving patient outcomes, the hospital actively participates in clinical trials across various therapeutic areas, fostering collaboration with academic institutions and industry partners to drive advancements in healthcare.

Locations

Metz, , France

Patients applied

0 patients applied

Trial Officials

Véronique DORVAUX, MD

Principal Investigator

CHR Metz Thionville Hopital de Mercy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials